Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Butterfly NetworkBFLYW 54 Debt-to-EBITDA is -0.38 as of Jun. 2026. GuruFocus rates BFLYW with a GF Score™ of 54/100. The stock has 6 warning signs investors should review. Among 473 Medical Devices & Instruments companies, Butterfly Network ranks worse than 211416.28% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Butterfly Network's Debt-to-EBITDA or its related term are showing as below:
BFLYW'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.98 Med: -0.32 Max: -0.2
Current: -0.28
During the past 7 years, the highest Debt-to-EBITDA Ratio of Butterfly Network was -0.20. The lowest was -0.98. And the median was -0.32.
BFLYW's Debt-to-EBITDA is ranked worse than 100% of 473
companies
in the Medical Devices & Instruments industry
Industry Median: 1.62
vs BFLYW: -0.28
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Butterfly Network Debt-to-EBITDA Related Terms
Butterfly Network Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Butterfly Network's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BFLYW vs ALMR, UFPT, ENOV: Debt-to-EBITDA Comparison
For the Medical Devices subindustry, Butterfly Network's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Butterfly Network Debt-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Butterfly Network's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Butterfly Network's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.
Butterfly Network (BFLYW) has a Debt-to-EBITDA of -0.38 as of Jun. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Butterfly Network. According to the industry distribution chart, Butterfly Network ranks #999999 out of 473 companies in the Medical Devices & Instruments industry.
Is Butterfly Network's Debt-to-EBITDA too high?
Butterfly Network's current Debt-to-EBITDA is -0.38. Based on the distribution chart, Butterfly Network ranks #999999 out of 473 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Butterfly Network has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does Butterfly Network's Debt-to-EBITDA compare to ALMR and UFPT?
According to the Medical Devices & Instruments industry distribution chart, Butterfly Network ranks #999999 out of 473 companies for Debt-to-EBITDA. This places Butterfly Network in the lower half of its industry. The industry median Debt-to-EBITDA is 1.62. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Medical Devices & Instruments company?
The median Debt-to-EBITDA among Medical Devices & Instruments companies is 1.62, based on 473 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Butterfly Network. For the Medical Devices & Instruments industry, the median Debt-to-EBITDA is 1.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Butterfly Network's current Debt-to-EBITDA is -0.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Butterfly Network stock overvalued right now?
Butterfly Network (BFLYW) has a current Debt-to-EBITDA of -0.38. The current Debt-to-EBITDA is -0.38. Butterfly Network's overall GF Score™ is 54/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Butterfly Network (BFLYW), the current Debt-to-EBITDA is -0.38 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. The company operates in one reportable segment, which includes all activities related to the development, manufacture, and sale of the Company's products, software, and other services.
54GF Score
Get the complete analysis for BFLYW
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BFLYW has been successfully added to your 
